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Abstract
Introduction—A neonatal illness severity score, The Score for Neonatal Acute Physiology-II 
(SNAP-II), predicts neurodevelopmental impairments at two years of age among children born 
extremely preterm. We sought to evaluate to what extent SNAP-II is predictive of cognitive and 
other neurodevelopmental impairments at 10 years of age.
Methods—In a cohort of 874 children born before 28 weeks of gestation, we prospectively 
collected clinical, physiologic and laboratory data to calculate SNAP-II for each infant. When the 
children were 10 years old, examiners who were unaware of the child's medical history assessed 
neurodevelopmental outcomes, including neurocognitive, gross motor, social, and communication 
functions, diagnosis and treatment of seizures or attention deficit hyperactivity disorder (ADHD), 
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academic achievement, and quality of life. We used logistic regression to adjust for potential 
confounders.
Results—An undesirably high SNAP-II (≥ 30), present in 23% of participants, was associated 
with an increased risk of cognitive impairment (IQ, executive function, language ability), adverse 
neurological outcomes (epilepsy, impaired gross motor function), behavioral abnormalities 
(attention deficit disorder and hyperactivity), social dysfunction (autistic spectrum disorder) and 
education-related adversities (school achievement and need for educational supports.
In analyses that adjusted for potential confounders, Z-scores ≤ -1 on 11 of 18 cognitive outcomes 
were associated with SNAP-II in the highest category and 6 of 18 were associated with SNAP-II in 
the intermediate category. Odds ratios and 95% confidence intervals ranged from 1.4 (1.01, 2.1) to 
2.1 (1.4, 3.1). Similarly, 2 of the 8 social dysfunctions were associated with SNAP-II in the highest 
category, and 3 of 8 were associated with SNAP-II in the intermediate category. Odds ratios and 
95% confidence intervals were slightly higher for these assessments, ranging from 1.6 (1.1, 2.4) to 
2.3 (1.2, 4.6).
Conclusion—Among very preterm newborns, physiologic derangements present in the first 12 
postnatal hours are associated with dysfunctions in several neurodevelopmental domains at 10 
years of age. We are unable to make inferences about causality.
Keywords
neurocognitive function; illness-severity scores; physiologic instability; SNAP-II; functional 
development; brain injury
Introduction
The Score for Neonatal Acute Physiology (SNAP),(1) and a revised version, the SNAP-II,(2) 
are physiology-based indicators of endogenous mortality risk based on routinely available 
vital signs and laboratory tests obtained during the first 12 postnatal hours, when clinical/
physiologic derangements are less likely to be influenced by medical interventions than 
derangements that occur later in the hospital course. SNAP-II not only predicts death among 
very preterm newborns, but also neonatal intraventricular hemorrhage,(3-5) respiratory 
dysfunction, (3-5) and retinopathy of prematurity.(5-7)
In the ELGAN Study of infants born before 28 weeks gestation, high SNAP-II predicted 
death, ultrasound-defined morphologic abnormalities of the brain, and low developmental 
scores at age 2 years.(8, 9) However, neurodevelopmental assessments at age 2 years have 
limited ability to predict later function, (10-12) and functional abilities at age 10 are 
qualitatively different and more complex than what can be assessed at age 2 years.(13, 14) 
Thus, we sought to extend our previous work by examining neurodevelopmental function at 
age 10 as an outcome associated with high SNAP-II.
The relationship between early indicators of physiologic instability and neurodevelopmental 
outcomes at school age is not yet known. In this report, we examine the relationship between 
SNAP-II and dysfunctions at 10 years in a cohort of children born extremely preterm at 14 
medical centers in the United States.
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Materials and Methods
Participants
The ELGAN study is a multi-center prospective, observational study of the risk of structural 
and functional neurologic disorders in extremely preterm infants.(15) A total of 1506 infants 
born before the 28th week of gestation were enrolled during the years 2002-2004 and 1200 
survived to 2 years. At age 10 years, 966 of these infants were recruited for an assessment of 
cognition, executive function, behaviors, and academic achievement. Of these 966 children, 
889 (92%) returned for follow up and 874 underwent neurocognitive testing. Enrollment and 
consent procedures for this follow up study were approved by the institutional review boards 
of each participating institution. Demographic, pregnancy and newborn variables were 
examined using a standardized protocol that has been reported by others.(15)
Revised Scores for Neonatal Acute Physiology (SNAP-II)
We collected all physiologic, laboratory and therapy data for the first 12 postnatal hours 
needed to calculate a SNAP-II.(2) We also identified cut-offs for each week of post-
menstrual age at birth that defined the top quartile, top decile, and three categories (<20, 
20-29, and ≥30) of SNAP-II.
10 year follow up visit
Families willing to participate were scheduled for one visit during which all of the 
assessments reported here were administered in 3 to 4 hours, including breaks. The 
assessments were selected to provide the most comprehensive information about 
neurocognitive and academic function in one testing session. A summary of the 
neurocognitive assessments used in this study is included as a supplemental table 
(Supplemental Tables 1a and 1b).
Examiners who were unaware of the child's medical history assessed neurodevelopment in 
several clinically important domains. While the child was tested, the parent or caregiver 
completed questionnaires regarding the child's educational, medical, neurological and 
behavioral status. Questionnaires were also provided to the child's school teacher to obtain 
teacher-reported behavioral status, as described below.
Neurocognitive and related outcomes
General cognitive ability was assessed with the School-Age Differential Ability Scales–II 
(DAS-II) Verbal and Nonverbal Reasoning scales.(16) Expressive and receptive language 
skills were evaluated with the Oral and Written Language Scales (OWLS. (17) Attention and 
executive function were assessed with both the DAS-II and NEPSY-II (A Developmental 
NEuroPSYchological Assessment-II).(18, 19) Speed of processing was assessed with 
NEPSY-II Inhibition Naming. Visual perception was assessed with NEPSY-II Arrows and 
Geometric Puzzles, while visual motor function was measured with NEPSY-II Visuomotor 
Precision and Fingertip Tapping. Academic function was assessed with the Wechsler 
Individual Achievement Test-III (WIAT-III [C]) which provides standard scores in word 
recognition and decoding, spelling, and numeric operations.(20) Educational outcomes 
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included receipt of an individual educational plan (IEP), repeating a grade in school, and 
placement in a remedial class.
Neurological outcomes
Neurological outcomes included the diagnosis of “any” seizures or epilepsy, receipt of anti-
epileptic drugs at the time of the assessment, and gross motor function.
Seizure identification was a two stage process. If parents answered “yes” to any of 11 broad 
questions for possible seizures, they were prompted by the study epileptologist to conduct a 
structured interview followed by an open-ended interview, both by telephone. The 
epileptologist then determined whether a reported event was a seizure. A second 
epileptologist independently reviewed interview responses and similarly rated the event type. 
When the two physicians' disagreed on the presence of seizures, which occurred in only 3% 
of the children interviewed, a third epileptologist reviewed the interview responses and made 
the final determination regarding seizure status.
Gross Motor Function was assessed using the Gross Motor Function Classification System 
(GMFCS).(21) Children with a GMCFS ≥3 (unable to walk without an assistive mobility 
device) were considered to have a significant gross motor abnormality.
Social Responsiveness
We used the Social Responsiveness Scale-2 (SRS-2) to identify social impairment and to 
quantify its severity.(22) This 65-item instrument provides a total score reflecting severity of 
social deficits in the autism spectrum, as well as five subscale scores for: social awareness, 
social cognition, social communication, social motivation, and restricted interests and 
repetitive behavior.
All children were screened by parent report for Autistic Spectrum Disorder (ASD) with the 
Social Communication Questionnaire (SCQ).(23) Children who screened positive on the 
SCQ were assessed with the Autism Diagnostic Interview – Revised (ADI-R), and an in-
depth parent interview.(24) Children meeting ADI-R modified criteria for ASD were 
administered the Autism Diagnostic Observation Schedule-2 (ADOS-2). (25, 26) Finally, all 
children meeting standardized research criteria for ASD on both the ADI-R and ADOS-2 
were classified as having ASD.
Behavioral outcomes
Behavioral outcomes were assessed in two ways, by physician diagnosis or treatment for 
ADHD, and by parental and teacher report of the behavioral status items included in the 
Child Symptom Inventory-4 (CSI-4).(27, 28) Teachers and parents did not make any DSM-
IV diagnosis. Rather, the CSI-4 functioned as a screening tool for determining a behavioral 
pattern, based on selected behavioral characteristics.
We operationalized the definition of ADHD, using a convention supported by others, to 
include any 2 of the following 3 ADHD designations: (1) parent report, (2) teacher report, 
and (3) physician diagnosis. Parent and teacher reports of a designation of ADHD are 
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reported in Table A. This definition confers a level of agreement sufficient to provide 
confidence in the child's designation as having ADHD.
Parent-reported Quality of Life
Although health-related quality of life is a complex and sometimes subjective domain, it also 
conveys information about the biologic impact of exposures on outcomes most important to 
families. For this reason, we examined five quality of life indicators found in the Pediatric 
Quality of Life Inventory™ (PedsQL™), including functional assessments of physical, 
emotional, social, school, and psychological functioning.(29, 30)
Data Analyses
We evaluated the null hypothesis that each measure of neurodevelopmental function at age 
10 years was not differentially distributed among children in three SNAP-II categories (< 20, 
20-29, and ≥ 30). In the ELGAN cohort, a SNAP-II ≥ 30 correlates roughly with the upper 
quartile.(8)
To allow for differences in age at the time of the assessment, and to facilitate a comparison 
to children born at term, we calculated Z-scores using the distributions of values reported in 
historical normative controls, as described by the authors of the assessments we used.(16, 
17, 19, 20)
For assessments of neurocognitive and social function, we created logistic regression models 
of the risk of a score 1 or more standard deviations below the normative mean for each 
assessment (i.e., Z-score ≤ -1). These models, which included potential confounders 
(maternal education, mother's eligibility for government-provided medical insurance, 
delivery for preeclampsia or fetal indication, gestational age, and birth weight Z-score), 
allowed us to calculate odds ratios (and 95% confidence intervals) indicating the strength of 
association between the SNAP-II category and each outcome.
For assessments of educational and neurologic function, behavior, and quality of life, we 
used a χ2 trend analysis to test the strength of the relationship between SNAP-II and parent 
and teacher-reported behavioral abnormalities. Similarly, a χ2 trend analysis was used for 
assessments included in the CSI-4.
Results
Sample characteristics (Table 1)
Of the 874 infants in this sample, 53% (N=460) had a SNAP-II below 20, 25% (N=215) had 
a SNAP-II between 20 and 29, and the remaining 23% (N=199) had a SNAP-II ≥ 30.
The maternal demographic characteristics associated with a SNAP-II ≥ 30 were younger age 
at delivery, not having a college education, not being married, and eligibility for 
government-provided (public) medical insurance. Maternal fever during the delivery 
admission, lower gestational age at birth and lower birth weight were all associated with a 
SNAP-II >30; fetal growth restriction, however, was not.
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Neurocognitive and related outcomes (Supplemental Table 2 and Figures 1 and 2)
Roughly one quarter of all children who had a SNAP-II ≥ 30 had a score 2 or more standard 
deviations below the normative mean on the DAS-II Verbal, OWLS Listening 
Comprehension, and OWLS Oral Expression, and WIAT-III Numeric operations 
assessments. The strength of the association between SNAP-II and both verbal IQ and 
OWLS, both of which are measures of language function, is strong. Almost one-third of all 
children with a SNAP-II ≥ 30 had measures of executive function (NEPSY-II) 2 or more 
standard deviations below the normative mean. In general, the higher the SNAP-II category, 
the lower the neurocognitive score.
The box and whisker plots (Figure 1) display the distribution of scores on each assessment 
separately, for each SNAP-II group. The central line in the box indicates the median (50th 
centile), while the top of the box indicates the 75th centile and the bottom of the box 
indicates the 25th centile. Children with higher SNAP-IIs had consistently lower scores on 
the DAS-II, OWLS, WIAT–III and NEPSY-II.
Odds ratios and 95% confidence intervals of a Z-score ≤ 1 displayed in forest plots (Figure 
2, top panel) indicate that children with a high SNAP-II were at significantly increased risk 
of scores one or more standard deviation below the normative mean on almost every 
cognitive test. In analyses that adjusted for potential confounders, Z-scores ≤ -1 on 11 of 18 
cognitive outcomes were associated with SNAP-II in the highest category, and Z-scores ≤ -1 
on 6 of 18 were associated with SNAP-II in the intermediate category. Odds ratio's and 95% 
confidence intervals ranged from 1.4 (1.01, 2.1) to 2.1 (1.4, 3.1) (Figure 2, bottom panel).
Social outcomes (Supplemental Table 3 and Figure 3)
Infants with an undesirable SNAP-II (≥ 20) had modestly increased total and component 
scores on the SRS, with higher scores reflecting increased social impairment. Fully 10% of 
boys in both the middle and high SNAP-II groups were considered to have ASD based on a 
positive Autism Diagnostic Observation Schedule - 2 (ADOS - 2) assessment compared to 
4% in the lowest SNAP-II group.
Infants in the middle and high SNAP-II groups were at significantly increased risk on the 
social motivation subscale of the SRS and a “positive” Social Communication Questionnaire 
(SCQ), which screens for ASD. In analyses that adjusted for potential confounders, 2 of the 
8 social outcomes were associated with SNAP-II in the highest category, and 3 of 8 social 
outcomes were associated with SNAP-II in the intermediate category. Odds ratio's and 95% 
confidence intervals ranged from 1.6 (1.1, 2.4) to 2.3 (1.2, 4.6) (Figure 3, bottom panel).
Educational, neurologic, behavioral and quality of life outcomes (Table 2)
Whereas approximately 40% of children with a SNAP-II in the lowest SNAP-II category 
required an individual education plan (IEP), 70% had an IEP if their SNAP-II was ≥ 30, and 
twice as many children with a SNAP-II ≥ 30 required remedial education, compared to those 
in the lowest SNAP-II category (Table 2). A high SNAP-II was significantly associated with 
receipt of an IEP (p < 0.001) and placement in a remedial class (p < 0.001).
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The rate of epilepsy increased significantly with increasing SNAP-II category (p = 0.03) as 
did the use of seizure medication (p = 0.03) at the time of the assessment.
A high SNAP-II was also associated with a GMFCS ≥3. Almost three times as many infants 
(8%) with a SNAP-II ≥ 30 and twice as many (6%) with a SNAP-II 20-29 had a GMFCS ≥ 
3, compared to those with a score < 20 (3%) (p= 0.007).
By and large, children with high SNAP-IIs had lower quality of life scores on the PedsQL™ 
inventory. A high SNAP-II was associated with adverse outcomes in 4 out of 5 domains, 
including physical, social, school, and psychosocial functioning (all p < 0.001).
Because parent and teacher-reported outcomes are less reliable than standardized 
neurocognitive testing, we did not include adjustments for potential confounders in these 
analyses. Nonetheless, we view these outcomes as meaningful clinical markers of the 
derangements we found in neurocognitive testing (Figures 2 and 3).
Behavioral outcomes (Supplemental Table 4)
The association between the diagnosis of ADHD and high SNAP-II appears to be stronger 
than that of treatment for ADHD and a high SNAP-II. The diagnosis of ADHD was more 
common among children with higher SNAP-IIs than among children who had lower SNAP-
IIs, both by parent report (p=0.03) and teacher report (p=0.003). Associations with other 
CSI-4-identified behaviors presented in Supplemental Table 4, are viewed largely as 
exploratory.
Discussion
In this sample of 10-year-old children born before the 28th week of gestation, those who had 
a SNAP-II ≥ 30 were at increased risk of neurocognitive, behavioral, and social 
dysfunctions. Children who had a high SNAP-II were also more likely than those with a low 
SNAP-II to have an IEP, to repeat a grade, to be placed in a remedial class, to be diagnosed 
or treated for ADHD, ASD, or epilepsy, to need an assistive device to ambulate, and to have 
diminished quality of life.
The characteristic most strongly associated with a high SNAP-II is gestational age, but 
within each gestational age group those with a SNAP-II ≥ 30 were at even greater risk of 
these dysfunctions than those with normal physiologic status.(31) Thus, high SNAPs convey 
risk information that supplements the risk information conveyed by low gestational age.
Most surprising, however, was the multitude of dysfunctions we found at 10 years among 
children with early physiologic derangements, even after adjusting for potential 
confounders. Arguing from Occam's razor, we seek a cohesive explanation for these 
observations. What characteristic or exposure that differentiates extremely preterm from 
term infants also differentiates those extremely preterm infants with a high SNAP-II from 
those with a lower SNAP-II?
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Possible explanations for our findings
We offer four explanations for the link between SNAP scores and brain injury in children 
born extremely preterm. Immaturity may contribute to physiologic instability, increase the 
risk for neonatal complications, or result in a paucity of endogenous neuroprotectors 
normally provided by placenta, all of which may be associated with brain injury. In addition, 
prenatal infection and/or inflammation associated with preterm birth may contribute to brain 
injury as well.
First, physiologic instability may be in the causal chain between immaturity (and its 
correlates) and brain injury. Accordingly, SNAP-II could be viewed as a marker or indicator 
for such risk. While both hypoxemia and hypotension, examples of physiologic instability, 
have been invoked to account for brain damage in very preterm newborns,(32-39) sufficient 
support for these claims has yet to be provided.(40-44) Further, despite efforts to improve 
physiologic stability,(41, 45-52) the rate of neurodevelopmental derangements among 
extremely preterm infants remains high in numerous studies.(43, 44, 53-57)
Second, high SNAP-II scores are associated with postnatal events such as bacteremia/sepsis, 
necrotizing enterocolitis, and chronic lung disease,(4, 58) which are associated with adverse 
brain-related outcomes.(59-62) In this way, SNAP-II could be viewed as a marker for 
subsequent neonatal adversities. Because these intervening disorders might be in the causal 
path between high SNAP-II and 10-year outcomes, they are not confounders. Therefore, we 
did not adjust for them in any of our analyses.
Third, elevated SNAP-II scores may convey information about immaturity/vulnerability, 
such as that attributable to a paucity of placenta-provided endogenous protectors (63), which 
are known to have beneficial neurotrophic effects on development. Consider that all babies 
of the same gestational age are not equally mature or vulnerable. From this perspective, 
SNAP-II provides additional information about physiologic maturation, serving as a marker 
for processes that are developmentally regulated, including the ability to synthesize growth 
factors and other proteins capable of protecting the brain.(63) SNAP-II has been correlated 
with corticospinal tract development, independent of both gestational age and postnatal risk 
factors, lending support to the theory argument that SNAP-II provides information about 
neurotrophic effects on brain maturation.(64)
Finally, systemic inflammation, which may be developmentally-regulated, puts the newborn 
brain at increased risk of multiple disturbances.(65-68) Although systemic inflammation 
differentiates very preterm from term newborns,(69) early physiologic derangements and 
first day of life elevations of circulatory inflammation-related proteins, in general, were not 
associated with systemic inflammation in the ELGAN Study.(70) The rate of maternal fever, 
which is associated with both chorioamnionitis and early-onset sepsis,(71, 72) however, was 
increased among those with a SNAP-II ≥ 30. Nonetheless, while preterm infants exposed to 
chorioamnionitis tend to have higher SNAP-IIs than children not so exposed,(73) the 
evidence that chorioamnionitis contributes to brain damage in very preterm newborn is 
mixed.(74-77).
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Strengths and limitations
Our study has several strengths. First, we included a large number of infants, making it 
unlikely that we have missed important associations due to lack of statistical power, or that 
we claimed associations that might reflect the instability of small numbers. Second, we 
selected infants based on gestational age, not birth weight, in order to minimize confounding 
due to factors related to fetal growth restriction.(78) Third, we collected all of our data 
prospectively. Fourth, attrition at neurocognitive assessment was only modest. The 
weaknesses of our study are those of all observational studies. We are unable to distinguish 
between causation and association as explanation for what we found.
Conclusion
SNAP-II provides information that supplements the risk information conveyed by 
gestational age, and conveys important information about infants' vulnerability to 
neurodevelopmental adversities 10 years later. We view the multiplicity of 
neurodevelopmental dysfunctions associated with a high SNAP-II as support for SNAP-II as 
a marker for immaturity/vulnerability. Support for or against this view could come from 
studies that evaluate the relationship between SNAP-II and developmentally-regulated 
biomarkers.
Because no other group has evaluated the relationship between SNAP during the first 12 
postnatal hours in very preterm newborns and their function 10 years later, we view our 
assessments as exploratory. We offer 95% confidence intervals of odds ratios to illustrate the 
range of values that might be expected when attempts are made to replicate our findings, or 
test associations between SNAPs and later function in somewhat different ways.
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Figure 1. 
1
. Box-and-whisker plots of each neurocognitive subtest by SNAP-II. All subtest Z-scores 
are adjusted to population norms. Key: light gray is < 25, medium gray is ≥ 25, < 30, dark 
gray is ≥ 30. The central line in the box indicates the median (50th centile), while the top of 
the box indicates the 75th centile and the bottom of the box indicates the 25th centile. 
V=Verbal, NV=Nonverbal reasoning, WM=Working memory, LC=Listening 
comprehension, OE=Oral expression, WR=Word reading, PwD=Pseudoword decoding, 
NO=Numerical operations, Sp=Spelling, AA=Auditory attention, RS= Auditory response 
set, INI= Inhibition inhibition, INS= Inhibition switching, AS= Animal sorting, INN= 
Inhibition naming, AW=Arrows, GEO=Geometric puzzles, VP=Visuomotor precision.
1Odds ratios whose lower bound is to the right of the 1.0 vertical line are statistically 
significant at the p < 0.05 level.
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Figure 2. 
1
. Forest plots of odds ratios (ORs) and 95% confidence intervals of a Z-score ≤ -1 on each 
DAS-II and NEPSY-II neurocognitive assessment at age 10 associated with a SNAP-II ≥ 30 
or a SNAP-II between 20 and 29. Odds ratios in the top panel are unadjusted while those in 
the bottom panel are adjusted for maternal education (≤ 12 and > 12, < 16 years), public 
insurance, delivery for preeclampsia or fetal indication, gestational age (23-24 and 25-26 
weeks) and birth weight Z-score (< -2 and ≥ -2, < -1).
1Odds ratios whose lower bound is to the right of the 1.0 vertical line are statistically 
significant at the p < 0.05 level.
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Figure 3. 
1
. Forest plots of odds ratios (ORs) and 95% confidence intervals of a T score ≥ 60 on the 
Social Responsiveness Scale (SRS-2) subtests, and of documented characteristics of ASD 
based on the Autism Diagnostic Observation Schedule-2 (ADOS-2) at age 10 associated 
with a SNAP-II ≥ 30 or a SNAP-II between 20 and 29. Odds ratios in the top panel are 
unadjusted while those in the bottom panel are adjusted for gestational age (23-24 and 25-6 
weeks), birth weight Z-score (< -2 and ≥ -2, < -1), delivery for maternal or fetal indications, 
and maternal fever with 48 hours of delivery.
1Odds ratios whose lower bound is to the right of the 1.0 vertical line are statistically 
significant at the p < 0.05 level.
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